BridgeBio Pharma, Inc. BBIO
NASDAQ · United States · Health Technology
$65.80-0.17 (-0.26%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.78 | -0.58 | -35.5% | $243.68M | +10.3% | -0.9%$84.48→$83.70 |
| Q1 2026 | 2026-05-07 | -0.84 | -0.70 | -20.0% | — | — | -1.0%$68.09→$67.39 |
| Q4 2025 | 2026-02-24 | -0.94 | -0.62 | -51.6% | — | — | -2.0%$67.91→$66.54 |
| Q3 2025 | 2025-10-29 | -0.72 | -0.78 | +7.7% | — | — | -1.8%$64.50→$63.37 |
| Q2 2025 | 2025-08-05 | -0.95 | -0.60 | -58.3% | — | — | — |
| Q1 2025 | 2025-04-29 | -0.99 | -1.00 | +1.0% | — | — | — |
| Q4 2024 | 2025-02-20 | -1.37 | -1.09 | -25.7% | — | — | — |
| Q3 2024 | 2024-11-12 | -1.08 | -0.86 | -25.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.